MYP_123558
Basic Information
Anakinra
Anticancer
Immunology Immune modulation Immunomodulatory activity
Immunology Inflammation modulation Anti-inflammatory
Standard
153 amino acids
C759H1186N208O232S10
Standard
Sequence
MRPSGRKSSKMQAFRIWDVNQKTFYLRNNQLVAGYLQGPNVNLEEKIDVVPIEPHALFLGIHGGKMCLSCVKSGDETRLQLEAVNITDLSENRKQDKRFAFIRSDSGPTTSFESAACPGWFLCTAMEADQPVSLTNMPDEGVMVTKFYFQEDE
Physicochemical Analysis
17257.44 Da
5.46
-3.33
-3.75
-0.0218
-0.41
0.56
-0.03
62.63
70.72
0.0915
15470.00
15720.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
7115.02
-73.19
245.0
241.0
575.0
1209.0
26.0
168.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0347977 VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]; Escherichia coli [Bacterium]
Peptide/protein therapeutic
9606;562
Structure & Mods
linear peptide/protein therapeutic [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Immunomodulatory Anti-inflammatory IL-1 receptor antagonist
NOMID patients = 5.7 h (range of 3.1 - 28.2 h)
RECORD: Rec_0386423 VERIFIED: NO
Provenance & Taxonomy
Homo sapiens [Animal]; Escherichia coli [Bacterium]
Interleukin
9606; 562
Structure & Mods
single-chain therapeutic peptide/protein [Linear]
canonical L-amino-acid peptide [L]
Glycosylation
Bio-Activity Profile
Anticancer Immunomodulatory
Healthy subjects = 4 - 6 hours